Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0112 Transporter Info
Gene Name	SLC16A8
Transporter Name	Monocarboxylate transporter 3
Gene ID	23539
UniProt ID	O95907

Post-Translational Modification of This DT
Overview of SLC16A8 Modification Sites with Functional and Structural Information
Sequence	M G A G G P R R G E G P P D G G W G W V V L G A C F V V T G F A Y G F P K A V S V F F R A L M R D F D A G Y S D T A W V S S I M L A M L Y G T G P V S S I L V T R F G C R P V M L A G G L L A S A G M I L A S F A T R L L E L Y L T A G V L T G L G L A L N F Q P S L I M L G L Y F E R R R P L A N G L A A A G S P V F L S A L S P L G Q Q L L E R F G W R G G F L L L G G L L L H C C A C G A V M R P P P G P G P R P R R D S A G D R A G D A P G E A E A D G A G L Q L R E A S P R V R P R R R L L D L A V C T D R A F A V Y A V T K F L M A L G L F V P A I L L V N Y A K D A G V P D T D A A F L L S I V G F V D I V A R P A C G A L A G L A R L R P H V P Y L F S L A L L A N G L T D L S S A R A R S Y G A L V A F C V A F G L S Y G M V G A L Q F E V L M A A V G A P R F P S A L G L V L L V E A A A V L I G P P S A G R L V D V L K N Y E I I F Y L A G S E V A L A G V F M A V A T N C C L R C A K A A P S G P G T E G G A S D T E D A E A E G D S E P L P V V A E E P G N L E A L E V L S A R G E P T E P E I E A R P R L A A E S V
PTM type	X-Phosphorylation X: Amino Acid

Phosphorylation
Serine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC16A8			[1]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	61
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC16A8 Serine 61 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC16A8			[2]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	356
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC16A8 Serine 356 has the potential to affect its expression or activity.
Threonine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC16A8			[1]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	71
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC16A8 Threonine 71 has the potential to affect its expression or activity.
Tyrosine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC16A8			[2]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	343
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC16A8 Tyrosine 343 has the potential to affect its expression or activity.

References
1	Quantitative phosphoproteomics of Alzheimer's disease reveals cross-talk between kinases and small heat shock proteins. Proteomics. 2015 Jan;15(2-3):508-519.
2	iTRAQ labeling is superior to mTRAQ for quantitative global proteomics and phosphoproteomics. Mol Cell Proteomics. 2012 Jun;11(6):M111.014423.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.